Pierre Savi
Thrombosis and Angiogenesis Department
Sanofi-Aventis Recherche & Développement
Toulouse
France
Name/email consistency: high
- Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapy. Savi, P., Herault, J.P., Duchaussoy, P., Millet, L., Schaeffer, P., Petitou, M., Bono, F., Herbert, J.M. J. Thromb. Haemost. (2008)
- The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. Savi, P., Zachayus, J.L., Delesque-Touchard, N., Labouret, C., Hervé, C., Uzabiaga, M.F., Pereillo, J.M., Culouscou, J.M., Bono, F., Ferrara, P., Herbert, J.M. Proc. Natl. Acad. Sci. U.S.A. (2006)